About
CRISP-engineered Bacteriophage Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalMicrobiomeNorth & South Carolina
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
759
By Phase
PHASE2: 1PHASE1: 1
By Status
COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05488340Lead Sponsor
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
PHASE2Recruiting
318 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2026
NCT04191148Lead Sponsor
Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli
PHASE1Completed
36 participants
Started: Dec 30, 2019 · Completed: Nov 19, 2020
NCT02156479Lead Sponsor
Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients
N/ACompleted
175 participants
Started: Jul 31, 2014 · Completed: Apr 30, 2018
NCT02083042Lead Sponsor
Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients
N/ACompleted
97 participants
Started: Aug 31, 2013 · Completed: Dec 31, 2015
NCT02630537Lead Sponsor
Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients
N/ACompleted
133 participants
Started: Oct 31, 2011 · Completed: Sep 30, 2012
Locations (1)
Headquarters
Morrisville, NC, United States
Map
Loading map...